The ROE as of November 2024 (TTM) for Reviva Pharmaceuticals Holdings, Inc. (RVPH) is 664.92%

According to Reviva Pharmaceuticals Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is 664.92%. This represents a change of -422.61% compared to the average of -206.11% of the last 4 quarters.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Historical ROE (quarterly & annually)

How has RVPH ROE performed in the past?

The mean historical ROE of Reviva Pharmaceuticals Holdings, Inc. over the last ten years is -66.45%. The current 664.92% ROE has changed -1100.57% with respect to the historical average. Over the past ten years (40 quarters), RVPH's ROE was at its highest in in the September 2023 quarter at 123.14%. The ROE was at its lowest in in the June 2023 quarter at -767.52%.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) ROE by Quarter and Year

Discovering the peaks and valleys of Reviva Pharmaceuticals Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Average ROE

How has RVPH ROE performed in the past?

The current ROE of Reviva Pharmaceuticals Holdings, Inc. (RVPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Reviva Pharmaceuticals Holdings, Inc. (RVPH) ROE vs. Peers

How is RVPH’s ROE compared to its peers?

Reviva Pharmaceuticals Holdings, Inc.’s ROE is less than Ocuphire Pharma, Inc. (0%), greater than Protalix BioTherapeutics, Inc. (-30.19%), greater than EyePoint Pharmaceuticals, Inc. (-30.89%), greater than SELLAS Life Sciences Group, Inc. (-43.01%), greater than IN8bio, Inc. (-629.45%), greater than Cue Biopharma, Inc. (-197.15%), greater than Lantern Pharma Inc. (-156.38%), greater than Gracell Biotechnologies Inc. (-56.90%), greater than Sigilon Therapeutics, Inc. (-15.56%), greater than ZyVersa Therapeutics, Inc. (-74.73%), greater than Kiromic BioPharma, Inc. (-25512.50%), less than Unicycive Therapeutics, Inc. (327.18%), greater than Athira Pharma, Inc. (-374.14%), greater than Fortress Biotech, Inc. (-115.63%), greater than ACADIA Pharmaceuticals Inc. (-240.30%), less than Cabaletta Bio, Inc. (25.83%), greater than null (-50.10%),

Build a custom stock screener for Reviva Pharmaceuticals Holdings, Inc. (RVPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Reviva Pharmaceuticals Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Reviva Pharmaceuticals Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.